Oculis Holding AG

OCS

Market cap$1.74 B

Rank#2204

SEC filings130

Oculis Holding AG trades as OCS and has a market capitalization of $1.74 B, making it the #2204 largest US-listed company by market value. This page tracks Oculis Holding AG through 130 SEC filings, with financial statements and metrics updated as new reports are filed.

Latest filings

Filing	Type	Filed
6-K	-	2026-05-14
6-K	-	2026-05-11
SCHEDULE 13G/A	-	2026-04-29
6-K	-	2026-04-21
SCHEDULE 13G/A	-	2026-03-27
Insider sale notice	144	2026-03-09
6-K	-	2026-03-04
F-3ASR	-	2026-03-04

Browse the full filing history (130 filings)

Recent press releases

Oculis Reports Q1 2026 Financial Results and Provides ... - Oculis2026-05-11
Oculis Reports Q1 2026 Financial Results and Provides Company Update | Oculis
Oculis Reports Q2 2025 Financial Results and Provides Company ...2025-08-21
Oculis Reports Q2 2025 Financial Results and Provides Company Update | Oculis
Oculis Reports Q1 Financial Results and Provides Company Update2025-05-08
Oculis Reports Q1 Financial Results and Provides Company Update | Oculis

Similar companies

The largest companies sharing Oculis Holding AG's SEC industry classification (pharmaceutical preparations).

LLYEli Lilly and Company$1.072 T OCS vs LLY

JNJJohnson & Johnson$573.98 B OCS vs JNJ

ABBVAbbVie Inc.$399.47 B OCS vs ABBV

MRKMerck & Co., Inc.$293.16 B OCS vs MRK

AZNAstraZeneca PLC$286.27 B OCS vs AZN

Frequently asked questions

What is Oculis Holding AG's market cap?

Oculis Holding AG (OCS) has a market capitalization of $1.74 B as of 2026-05-29, ranking #2204 among US-listed companies.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.